The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue
Open accessAbstract
Dopamine is an inhibitory neurotransmitter involved in the pathology of schizophrenia. The revised dopamine hypothesis states that dopamine abnormalities in the mesolimbic and prefrontal brain regions exist in schizophrenia. However, recent research has indicated that glutamate, GABA, acetylcholine, and serotonin alterations are also involved in the pathology of schizophrenia. This review provides an in-depth analysis of dopamine in animal models of schizophrenia and also focuses on dopamine and cognition. Furthermore, this review provides not only an overview of dopamine receptors and the antipsychotic effects of treatments targeting them but also an outline of dopamine and its interaction with other neurochemical models of schizophrenia. The roles of dopamine in the evolution of the human brain and human mental abilities, which are affected in schizophrenia patients, are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–223 of 223
Dopamine D2Highreceptors moderately elevated by bifeprunox and aripiprazole
Seeman, P. M. (2008) · Synapse · doi:10.1002/syn.20557 · Cited by 26
Ferraro, L., Tomasini, M. C., Fuxé, K., Agnati, L. F., Mazza, R., Tanganelli, S., & Antonelli, T. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.03.006 · Cited by 26
Domyo, T., Kurumaji, A., & Toru, M. (2001) · Journal of Neural Transmission · doi:10.1007/s007020100021 · Cited by 25
Brisch, R., Bernstein, H., Krell, D., Dobrowolny, H., Bielau, H., Steiner, J., Gos, T., Funke, S., Stauch, R., Knüppel, S., et al. (2009) · Brain Research · doi:10.1016/j.brainres.2009.02.039 · Cited by 24
Self-citationKim, J., Son, Y., Kim, H.-K., Lee, S., Cho, S., Kim, Y.-B., & Cho, Z. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318222353a · Cited by 24
Functional differences between D1 and D5 revealed by high resolution imaging on live neurons
Kruusmägi, M., Kumar, S., Zelenin, S. M., Brismar, H., Aperia, A. C., & Scott, L. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.052 · Cited by 21
Klejbor, I., Kucinski, A. J., Wersinger, S. R., Corso, T. D., Spodnik, J. H., Dziewíatkowski, J., Moryś, J., Hesse, R. A., Rice, K. C., Miletich, R. S., et al. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.06.006 · Cited by 21
Gao, M., Chu, H., Jin, G.-Z., Zhang, Z., Wu, J., & Zhen, X. (2010) · Synapse · doi:10.1002/syn.20855 · Cited by 21
Bay-Richter, C., O’Callaghan, M. J., Mathur, N., O’Tuathaigh, C. M. P., Heery, D. M., Fone, K. C. F., Waddington, J. L., & Moran, P. M. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.50 · Cited by 20
Peselmann, N., Schmitt, A., Gebicke‐Haerter, P. J., & Zink, M. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0367-y · Cited by 19
PET neuroimaging of extrastriatal dopamine receptors and prefrontal cortex functions
Takahashi, H. (2013) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2013.07.001 · Cited by 19
Glutamate agonists for schizophrenia stimulate dopamine D2High receptors
Seeman, P. M. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.007 · Cited by 19
Balla, A., Schneider, S., Sershen, H. W., & Javitt, D. C. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.03.006 · Cited by 18
Ikeda, H., Kamei, J., Koshikawa, N., & Cools, A. R. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12r02cr · Cited by 18
Glass, M. J., Robinson, D. C., Waters, E. M., & Pickel, V. M. (2013) · Synapse · doi:10.1002/syn.21637 · Cited by 17
Seeman, P. M. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2008.12.024 · Cited by 16
Pauli, A., Prata, D. P., Mechelli, A., Picchioni, M., Fu, C. H. Y., Chaddock, C. A., Kane, F., Kalidindi, S., McDonald, C., Kravariti, E., et al. (2012) · Human Brain Mapping · doi:10.1002/hbm.22061 · Cited by 15
Adaptive properties and heterogeneity of dopamine D2 receptors – Pharmacological implications
Carlsson, A., & Carlsson, M. L. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.007 · Cited by 15
Arai, S., Shibata, H., Sakai, M., Ninomiya, H., Iwata, N., Ozaki, N., & Fukumaki, Y. (2008) · Psychiatric Genetics · doi:10.1097/ypg.0b013e328311875d · Cited by 12
Kwek, P., & van den Buuse, M. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.11.041 · Cited by 11
López, L. M., Wassef, A. A., Molloy, M., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300461 · Cited by 10
Maheux, J., St‐Hilaire, M., Voyer, D., Tirotta, E., Borrelli, E., Rouillard, C., Rompré, P.-P., & Lévesque, D. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00153 · Cited by 7
Glutamatergic Synaptic Dysregulation in Schizophrenia
Coyle, J. T., Basu, A. C., & Benneyworth, M. A. (2012) · Wiley eBooks · doi:10.1002/9781118309421.ch5 · Cited by 2
Cited by
Novel psychoactive substances of interest for psychiatry
Schifano, F., Orsolini, L., Duccio Papanti, G., & Corkery, J. M. (2015) · World Psychiatry · doi:10.1002/wps.20174 · Cited by 321
Optogenetic dissection of medial prefrontal cortex circuitry
Riga, D., Matos, M. R., Glas, A., Smit, A. B., Spijker, S., & Van den Oever, M. C. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00230 · Cited by 208
Lipids in Psychiatric Disorders and Preventive Medicine
Schneider, M., Levant, B., Reichel, M., Gulbins, E., Kornhuber, J., & Müller, C. P. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.002 · Cited by 175
Healy-Stoffel, M., & Levant, B. (2018) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527317666180412153612 · Cited by 133
Hunter, A., Murray, R., Asher, L., & Leonardi-Bee, J. (2020) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty160 · Cited by 95
Metadata
- Authors
- Brisch, R., Saniotis, A., Wolf, R., Bielau, H., Bernstein, H.-G., Steiner, J., Bogerts, B., Braun, A. K., Jankowski, Z., Kumaritlake, J., Henneberg, M., & Gos, T.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2014-05-19
- Volume
- 5
- Pages
- 47-47
- ISSN
- 1664-0640 (ISSN-L)
- OpenAlex
- W2016445640
- Cited by
- 517
- References
- 223
- FWCI
- 20.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.